Search - tctmd.com

Displaying 961 - 980 of 1133

Sort: Relevancy | Date

News Daily News

DES Appear Safe and Effective in SVG PCI

Salynn Boyles

October 24, 2014

News Daily News

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

October 10, 2014

News Daily News

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

L.A. McKeown

October 10, 2014

News Daily News

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

L.A. McKeown

October 03, 2014

News Daily News

European Societies Release Updated Revascularization Guidelines for CAD

L.A. McKeown

September 11, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Conference News ESC 2014

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

Yael L. Maxwell

August 31, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Daily News

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

Todd Neale

August 22, 2014

News Daily News

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

August 20, 2014

News Daily News

La Calidad de Vida de Pacientes con Claudicación Intermitente es Mejor con Tratamientos Invasivos

August 20, 2014

News Daily News

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

August 20, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

May 30, 2014

News Conference News EuroPCR 2014

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Yael L. Maxwell

May 21, 2014

News Daily News

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

L.A. McKeown

May 13, 2014

News Daily News

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

May 12, 2014

News Daily News

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

April 21, 2014

News Daily News

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

L.A. McKeown

April 11, 2014

News Daily News

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

L.A. McKeown

April 11, 2014

Advertisement

DES Appear Safe and Effective in SVG PCI

Studies Explore Impact of Diabetes on Platelet Reactivity in Clopidogrel-Treated PCI Patients

Stroke, Systemic Embolism Risk Higher When Amiodarone Combined with Warfarin Rather Than Apixaban

CORONOR Registry: Long-term Warfarin Plus Antiplatelet Increases Bleeding in Stable CAD Patients

European Societies Release Updated Revascularization Guidelines for CAD

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

SOLID-TIMI 52: Darapladib Fails to Reduce Adverse Events After ACS

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Similar Overall Long-Term Outcomes, Less Stent Thrombosis with Newer DES in STEMI

SYNTAX at 5 Years: CABG Holds Cost-Effectiveness Edge Over PCI

La Calidad de Vida de Pacientes con Claudicación Intermitente es Mejor con Tratamientos Invasivos

Intermittent Claudication Patients Have Better Quality of Life With Invasive Treatment

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Pre-PCI Trimetazidine Strategy Reduces CIN, Myocardial Injury in Diabetic Patients with Mild-to-Moderate CKD

PARIS Registry: Sex Disparity in DAPT Cessation Arises from Comorbidities

Meta-analysis: Bone Marrow Stem Cell Research Riddled with Discrepancies

Preclinical Study Casts Doubt on Regenerative Ability of Special Cardiac Stem Cells

First-in-Man Study Demonstrates Safety, Feasibility of Adipose-Derived Cell Therapy for Heart Failure

Diabetes Drug Aleglitazar Fails to Reduce Ischemic Outcomes in Diabetics with Recent ACS

Registry: DAPT Discontinuation Less Associated With Second-Gen DES Thrombosis Compared to First-Gen DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content